Correlation of del13q, del11q and trisomy 12 with laboratory and clinical features of chronic lymphocytic leukemia in Iranian patients

Iranian Red Crescent Medical Journal

Volumn 12, Issue 5, 2010, Pages 553-558

  Teimori, H ^a   Akbari, M T ^a   Toogeh, G R ^b   Khaleghian, M ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CD markers; Chromosomal aberrations; Chronic lymphocytic leukemia; Iran; Rai stages

Indexed keywords

CD38 ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; B CELL LEUKEMIA; BLOOD SAMPLING; BONE MARROW BIOPSY; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; FAMILY HISTORY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENETIC MARKER; HUMAN; LABORATORY TEST; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SEX DIFFERENCE; TRISOMY 12;

EID: 77957364810     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Amiel A, Leopold L, Gronich N, Yukla M, Fejgin MD, Lishner M. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia. Cancer Genet Cytogenet 2006;167:145-9. [16737914][doi:10.1016/j.cancergencyto.2005.11.019]
2. Karimi M, Mehrabani D, Yarmohammadi H, SafaeiJahromi F. The prevalence of signs and symptoms of childhood leukemia and lymphoma in Fars Province, Southern Iran. Cancer Detect Prev 2008;32:178-83. [18632219] [doi: 10.1016/j.cdp.2008.06.001]
3. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848-54. [10477713]
4. Kharfan-Dabaja MA, Chavez JC, Khorfan KA, Pinilla-Ibarz J. Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia. Cancer 2008;113:897-906. [18618 518] [doi:10.1002/cncr.23671]
5. Ramzi M. Hematopoietic stem cell transplantation in Southern Iran: History, current status and future direction. Iran Red Crescent Med J 2009;11:364-370.
6. Glassman AB, Hayes KJ. The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia. Cancer Genet Cytogenet 2005;158:88-91. [15771912] [doi:10.1016/j.canc-ergencyto.2004.08.012]
7. Oscier D. Biology and prognosticfactors in CLL. Hematology 2005; 10:197-9. [16188672] [doi:10.1080/102 45330512331390410]
8. Xu W, Li JY, Wu YJ, Yu H, Shen QD, Li L, Fan L, Qiu HX. Prognostic significance of ATM and TP53 dele-tions in Chinese patients with chron-ic lymphocytic leukemia. Leuk Res 008;32:1071-7. [18035414] [doi:10.1016/j.leukres.2007.10.009]
9. Sánchez J, Aventín A. Detection of chromosomal abnormalities in chronic lymphocytic leukemia increased by interphase fluorescence in situ hybridization in tetradecanoylphorbol acetate- stimulated peripheral blood cells. Cancer Genet Cytogenet 2007; 175:57-60. [17498559] [doi:10.1016/j.cancergencyto.2007.01.005]
10. Aoun P, Blair HE, Smith LM, Dave BJ, Lynch J, Weisenburger DD, Pavletic SZ, Sanger WG. Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk Lymphoma 2004;45:1595-603. [1537 0211][doi:10.1080/1042819041000 1680546]
11. Chang YH, Park J, Kim HC, Chun HK, Kim YR, Kim M, Han K, Lee JH, Lee KH. Korean patients with chronic lymphocytic leukemia show the similar types of chromosomal aberrations as those in Europe and North America. Leuk Res 2006;30:695-9. [16297977] [doi:10.1016/j.leukres.2005.10.013]
12. Kearney L, Horsely SH. Molecular cytogenetics in hematological malignancy: Current technology and future prospects. Chromosoma 2005; 114:286-94. [16003502] [doi:10.1007/s00412-005-0002-z]
13. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87:4990-7. [8652811]
14. ISCN. An international system for human cytogenetic nomenclature. In: Mitelman F, editor. Basel: S.Karger, 1995.
15. Ng D, Toure O, Wei MH, Arthur DC, Abbasi F, Fontaine L, Marti GE, Fraumeni JF Jr, Goldin LR, Caporaso N, Toro JR. Identification of a novel chromosome region 13q 21.33-q22.2, for susceptibility genes in familial chronic lymphocytic leu-kemia. Blood 2007;109:916-25. [17 047154] [doi:10.1182/blood-2006-03-011825]
16. Aoun P, Zhou G, Chan WC, Page C, Neth K, Pickering D, Sanger W, Quinn-Laquer B, Watson P, Lynch JF, Lynch HT, Weisenburger DD. Familial B-cell chronic lymphocytic leukemia: analysis of cytogenetic abnormalities, immunophenotypic profiles, and immunoglobulin heavy chain gene usage. Am J Clin Pathol 2007;127:31-8. [17145621] [doi:10. 1309/PFTPLL4HCK2D1ERK]